BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7488241)

  • 1. Structure-activity relationship of verapamil analogs and reversal of multidrug resistance.
    Toffoli G; Simone F; Corona G; Raschack M; Cappelletto B; Gigante M; Boiocchi M
    Biochem Pharmacol; 1995 Oct; 50(8):1245-55. PubMed ID: 7488241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
    Toffoli G; Corona G; Gigante M; Boiocchi M
    Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
    Toffoli G; Simone F; Gigante M; Boiocchi M
    Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil.
    Pesić M; Podolski A; Rakić L; Ruzdijić S
    Invest New Drugs; 2010 Aug; 28(4):482-92. PubMed ID: 19533022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.
    Consoli U; Priebe W; Ling YH; Mahadevia R; Griffin M; Zhao S; Perez-Soler R; Andreeff M
    Blood; 1996 Jul; 88(2):633-44. PubMed ID: 8695811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the optical isomers of KR30031 on cardiotoxicity and on multidrug resistance reversal activity.
    Lee BH; Lee CO; Kwon MJ; Yi KY; Yoo SE; Choi SU
    Anticancer Drugs; 2003 Feb; 14(2):175-81. PubMed ID: 12569305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cells.
    Toffoli G; Corona G; Sorio R; Bertola A; Boiocchi M
    Int J Cancer; 1997 May; 71(5):900-6. PubMed ID: 9180163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enhancement of cytotoxic effect of anticancer agents of renal cell carcinoma].
    Okano M; Kawamoto S; Nezasa S; Tamaki M; Ehara H; Yamada S; Deguchi T; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1041-7. PubMed ID: 8831211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity.
    Jonsson O; Behnam-Motlagh P; Persson M; Henriksson R; Grankvist K
    Biochem Pharmacol; 1999 Dec; 58(11):1801-6. PubMed ID: 10571255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells.
    Liu Y; Cho CW; Yan X; Henthorn TK; Lillehei KO; Cobb WN; Ng KY
    Pharm Res; 2001 Sep; 18(9):1255-61. PubMed ID: 11683237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression.
    Nygren P; Larsson R; Gruber A; Peterson C; Bergh J
    Br J Cancer; 1991 Dec; 64(6):1011-8. PubMed ID: 1684906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
    Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
    J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line.
    Huang M; Liu G
    Cancer Lett; 1999 Jan; 135(1):97-105. PubMed ID: 10077227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells.
    Teodori E; Braconi L; Bua S; Lapucci A; Bartolucci G; Manetti D; Romanelli MN; Dei S; Supuran CT; Coronnello M
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
    Shrivastava P; Hanibuchi M; Yano S; Parajuli P; Tsuruo T; Sone S
    Cancer Chemother Pharmacol; 1998; 42(6):483-90. PubMed ID: 9788575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation.
    Hu YP; Chapey C; Robert J
    Cancer Lett; 1996 Dec; 109(1-2):203-9. PubMed ID: 9020922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.